Roche reportedly pursuing buyout of genomics company Pacific Biosciences of California

Shares of Menlo Park's Pacific Biosciences ($PACB) of California are up 25% on a report that Big Pharma (and diagnostics) player Roche ($RHHBY) is interested in acquiring the provider of gene sequencing technology. The company makes the Sequel System for single-molecule, real-time sequencing. More

Read more on